Related Experiment Video
Updated: Aug 29, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
Cardiomyocyte-specific desmin rescue of desmin null cardiomyopathy excludes vascular involvement
Noah Weisleder1, Elisavet Soumaka, Shahrzad Abbasi
1Department of Molecular and Cellular Biology, Baylor College of Medicine, One Baylor Plaza Texas Medical Center, Houston, TX 77030, USA.
Insights
Desmin deficiency causes heart defects in mice. Restoring desmin in cardiomyocytes prevents dilated cardiomyopathy, proving the defect is intrinsic to heart muscle cells, not blood vessels.
Area of Science:
- Cardiovascular Biology
- Muscle Physiology
- Intermediate Filament Biology
Background:
- Desmin is a muscle-specific intermediate filament protein crucial for muscle integrity.
- Desmin deficiency in mice leads to severe cardiac defects, including dilated cardiomyopathy (DCM), myocyte death, fibrosis, and ultrastructural abnormalities.
- Previous studies suggested potential vascular dysfunction in desmin-null hearts, but the primary cause of DCM remained unclear.
Purpose of the Study:
- To elucidate whether dilated cardiomyopathy in desmin-null mice stems from intrinsic cardiomyocyte defects or impaired coronary vascular function.
- To investigate the role of cardiomyocyte-specific desmin expression in rescuing cardiac phenotype.
Main Methods:
- Generation of transgenic mice with cardiomyocyte-specific desmin rescue.
- Assessment of cardiac phenotype, including histology (fibrosis, calcification), ultrastructure, and myocyte hypertrophy markers.
- Functional evaluation of working hearts, measuring coronary flow and cardiac power.
Main Results:
- Desmin rescue mice exhibited a wild-type cardiac phenotype, with normalized myocardium, absence of fibrosis and calcification, and restored coronary flow.
- Cardiomyocyte ultrastructure and hypertrophy markers were normalized in desmin rescue mice compared to desmin-null counterparts.
- Functional assessments confirmed improved cardiac performance in desmin-rescued hearts.
Conclusions:
- The study demonstrates that desmin's role in the heart is intrinsic to cardiomyocytes.
- Dilated cardiomyopathy in desmin-null mice is caused by an intrinsic cardiomyocyte defect, not by compromised coronary circulation.
- Targeted restoration of desmin in cardiomyocytes effectively rescues the cardiac phenotype, highlighting desmin's critical function in maintaining cardiac structure and function.
Abstract:
Mice deficient in desmin, the muscle-specific member of the intermediate filament gene family, display defects in all muscle types and particularly in the myocardium. Desmin null hearts develop cardiomyocyte hypertrophy and dilated cardiomyopathy (DCM) characterized by extensive myocyte cell death, calcific fibrosis and multiple ultrastructural defects. Several lines of evidence suggest impaired vascular function in desmin null animals. To determine whether altered capillary function or an intrinsic cardiomyocyte defect is responsible for desmin null DCM, transgenic mice were generated to rescue desmin expression specifically to cardiomyocytes. Desmin rescue mice display a wild-type cardiac phenotype with no fibrosis or calcification in the myocardium and normalization of coronary flow. Cardiomyocyte ultrastructure is also restored to normal. Markers of hypertrophy upregulated in desmin null hearts return to wild-type levels in desmin rescue mice. Working hearts were perfused to assess coronary flow and cardiac power. Restoration of a wild-type cardiac phenotype in a desmin null background by expression of desmin specifically within cardiomyocyte indicates that defects in the desmin null heart are due to an intrinsic cardiomyocytes defect rather than compromised coronary circulation.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
